APA (7th ed.) Citation

Mölken, M. R., Hoogendoorn, M., Ramos, I. C., Soulard, S., Cook, J., Soini, E., & Paulsson, E. Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: A model-based study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Mölken, Maureen Rutten-van, Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, Jennifer Cook, Erkki Soini, and Emma Paulsson. Cost-effectiveness of the Fixed-dose Combination Tiotropium/olodaterol Versus Tiotropium Monotherapy or a Fixed-dose Combination of Long-acting β2-agonist/inhaled Corticosteroid for COPD in Finland, Sweden and the Netherlands: A Model-based Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Mölken, Maureen Rutten-van, et al. Cost-effectiveness of the Fixed-dose Combination Tiotropium/olodaterol Versus Tiotropium Monotherapy or a Fixed-dose Combination of Long-acting β2-agonist/inhaled Corticosteroid for COPD in Finland, Sweden and the Netherlands: A Model-based Study. BMJ Publishing Group.